POC Diagnostics: 4 Considerations For Bridging The Gap From Development To Commercialization

Bridging the gap between a successful point-of-care (POC) assay prototype and full-scale commercialization requires early strategic alignment across design, chemistry, and high-volume production. Modern diagnostic consumables demand precision microfluidics, integrated reagent handling, and automated assembly to transition smoothly from benchtop prototypes to scalable manufacturing. By addressing key operational pillars—such as designing robust injection-molded components, integrating chemical formulation directly into assembly, establishing scalable cartridge fabrication, and executing early validation testing—developers can significantly mitigate technical risk. Unifying these complex development phases reduces supply chain vulnerabilities, controls production costs, and accelerates time-to-market.
Explore the core considerations necessary to successfully scale diagnostic consumables and optimize the journey to commercial readiness.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.